Clinical Trial Update: Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura [NA]

View source ↗

Summary

A clinical trial update reports eltrombopag-associated liver dysfunction observed during treatment of immune thrombocytopenia, highlighting a safety signal requ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Sohag University | Conditions: ITP - Immune Thrombocytopenia | NA | Status: RECRUITING